Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026

Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026

Understand how pharmaceutical and biotechnology companies share development responsibilities, investment, risk and commercial opportunity through co-development partnerships.

Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 1,069 co-development deals announced across the pharmaceutical and biotechnology sectors.

The report examines how companies collaborate to advance assets and technologies through development, combining expertise, resources and capabilities while allocating development responsibilities, costs, rights and future commercial opportunities between partners.

Rather than simply identifying transactions, the report enables users to understand who is entering co-development partnerships, where activity is concentrated, how agreements are structured, and what can be learned from disclosed financial terms and publicly available contract documents.

It provides a practical intelligence and benchmarking resource for business development, licensing, corporate strategy, R&D strategy, alliance management and legal teams involved in evaluating, structuring or negotiating collaborative development partnerships.

Understand the co-development deal landscape

The report analyzes co-development activity from 2016 to 2026, including:

• Trends in co-development dealmaking by year
• Stage of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active co-development dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering co-development partnerships
• How co-development dealmaking is evolving
• This enables users to see where collaborative development activity is concentrated, which companies are most active and how co-development strategies differ across technologies, therapeutic areas and stages of development.
• Understand how co-development agreements are structured
• Co-development partnerships require the parties to determine how development activity, funding, decision-making, intellectual property and future rights will be allocated.

The report provides intelligence to help users examine areas including:

• Development responsibilities
• Research and development funding
• Cost-sharing arrangements
• Intellectual property ownership and rights
• Governance and decision-making
• Development milestones
• Regulatory responsibilities
• Commercialization rights
• Geographic and market rights
• Manufacturing and supply responsibilities
• Financial terms where disclosed
• Term and termination provisions
• This provides useful reference points for teams assessing potential co-development structures and preparing for partnering discussions.
• Benchmark leading deals and financial terms
• The report identifies leading co-development transactions by disclosed deal value and provides access to available financial information associated with individual agreements.
• Users can investigate headline deal values, upfront payments, milestone structures, equity components and other disclosed economics where available.
• This helps place proposed transactions into the context of comparable real-world deals and supports evidence-based deal preparation and benchmarking.
• Identify leading co-development dealmakers
• The report profiles the Top 25 most active co-development dealmakers, providing insight into the companies most frequently using collaborative development partnerships.

Understanding who is actively entering these agreements can support:

• Partner identification
• Competitor analysis
• Search and evaluation
• Business development strategy
• Assessment of partnering behaviour
• Individual deal histories allow users to investigate how specific companies have approached co-development across multiple transactions.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying co-development contract documents.
• These agreements provide greater detail than company announcements alone and can reveal how selected partners have addressed development obligations, governance, intellectual property, cost allocation, commercialization rights, milestones, termination and other negotiated provisions.
• For teams preparing for or negotiating a co-development agreement, these real-world examples provide valuable insight into how comparable transactions have been documented in practice.
• Comprehensive co-development deal directory
• The report includes a comprehensive directory of 1,069 co-development deals, allowing users to identify transactions relevant to their own assets, technologies and partnering objectives.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Identify relevant precedent transactions, potential partners and deal structures when preparing for co-development discussions.
• R&D and Portfolio Strategy teams
• Understand how companies are using partnerships to share development responsibilities, capabilities and investment.
• Corporate Strategy teams
• Track collaborative development activity and understand how competitors and potential partners are approaching external innovation.
• Alliance Management teams
• Examine how development responsibilities, governance and ongoing partner obligations have been structured in comparable agreements.
• Legal and Transaction teams
• Review deal structures and publicly available contract language to support agreement preparation and negotiation.
• Competitive and Market Intelligence teams
• Analyze deal activity by company, development stage, therapy area and technology to identify important partnering trends.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying deal intelligence to the customer's own business, assets, technologies or partnering objectives.
• Depending on requirements, this can include relevant comparable deals, prospective partners, competitor activity, development-stage benchmarking, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.